 |

Ocular
Microbiology and Immunology Group
Back
to OMIG Main Page
< Previous | 2026 Agenda and Abstracts | Next >
2026 OMIG Abstract
POSTER PRESENTATION
Differences in Tear Sphingolipid Composition Across Dry Eye Disease Subtypes
Patricia Fuentes1,2, Laura Beatriz Paule Jimenez1,2, Anat Galor1,2, and Nawajes Mandal3
1Miami Veterans Administration Medical Center, Miami, Florida; 2Bascom Palmer Eye Institute, University of Miami, Miami, Florida; 3Departments of Ophthalmology, Anatomy and Neurobiology, University of Tennessee Health Sciences Center, Hamilton Eye Institute, Memphis, Tennessee
Purpose: To compare tear sphingolipid (SPL) profiles, including ceramides (Cer), sphingomyelins (SM), and monohexosylceramide (MHC), among clinically defined dry eye phenotypes, including aqueous tear deficiency (ATD), meibomian gland dysfunction (MGD), and pain-predominant dry eye.
Methods: 49 Veterans at the Miami Veterans Affairs (VA) eye clinic were examined. Demographics and medical history were self-reported. Ocular Surface Disease Index (OSDI) and 5-Item Dry Eye Questionnaire (DEQ-5) questionnaires were used to assess symptoms. All participants underwent a tear film and ocular surface examination. Dry eye phenotypes were assigned using the following criteria: ATD was defined by Schirmer <8mm, MGD was defined by preserved tear production (Schirmer > 8 mm) with at least one meibomian gland (MG) abnormality (MG quality > 2, MG dropout > 2, or MG plugging > 2), pain-phenotype was defined by OSDI > 23, DEQ-5 > 9 or pain score > 2, together with preserved ocular surface findings (Schirmer > 8mm, TBUT >5 seconds, and corneal staining < 2). Tear lipid samples were analyzed using targeted liquid chromatography-tandem mass spectrometry. Statistical analyses included nonparametric and parametric comparisons, as appropriate; p=0.05 was considered statistically significant. Values are reported as mean + SD.
Results: Of the 49 participants, there were 13 ATD, 27 MGD, and 9 pain-phenotype. In the entire population, the mean age was 57 years and 84% were male, without significant differences across the groups. As expected, Schirmer test results were lowest in the ATD group (6.1 mm) versus the MGD (18.89 mm) and pain (19.00 mm) groups while MG parameters were more severe in the MGD group compared to the other two groups (MG quality: ATD 1.36, MGD 2.15, pain 0.33; MG dropout: ATD 1.07, MGD 1.78, pain 0.67), p<.001 for all. However, DED symptoms (OSDI, DEQ-5) and other signs (TBUT, corneal staining, MG plugging) were similar across groups. SPL composition differed across groups. The ATD group had higher total Cer levels than the MGD group (460.18+445.80 vs 178.80+283.01pmol; p=.004) and a higher relative Cer composition (16.92+4.87% vs 11.52+2.80%; p<.001). In contrast, the relative proportion of total MHC was higher in the MGD group than in the ATD group (4.64+2.35% vs 2.38+0.83%; p<.001).The same pattern was noted when looking at SPL sub-species with the ATD group having higher levels of several Cer species (16:0, 18:1, 22:0, 24:1, 24:0, 26:1) compared to the MGD and pain phenotypes.
Conclusions: The ATD phenotype exhibited higher absolute tear Cer, as well as greater relative Cer composition, suggesting a more inflammatory tear lipid profile compared to the MGD and pain phenotypes.
Disclosure: N
Support: Supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&D (CSRD) I01 CX002015 (AG) and Biomedical Laboratory R&D (BLRD) Service I01 BX004893 (AG, NM), Department of Defense Gulf War Illness Research Program (GWIRP) W81XWH-20-1-0579 (AG) and Vision Research Program (VRP) W81XWH-20-1-0820 (AG), National Eye Institute R01EY026174 (AG) and R61EY032468 (AG), NIH Center Core Grant P30EY014801 (institutional) and Research to Prevent Blindness Unrestricted Grant (institutional).
< Previous | 2026 Agenda and Abstracts | Next >
|

|